NEWS
Free Institutional Consultancy Services
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 220 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Sayeda Kamrun Naher
University of Sydney - Sydney / Australia
Medical and Health Sciences / Medical Oncology
AD Scientific Index ID: 5148764
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Sayeda Kamrun Naher's MOST POPULAR ARTICLES
1-)
An updated systematic review of quantitative studies assessing anxiety, depression, fear of cancer recurrence or psychological distress in testicular cancer survivorsO Rincones, AB Smith, S Naher, R Mercieca-Bebber, M StocklerCancer Management and Research, 3803-3816, 2021192021
2-)
Patient-reported outcomes associated with treatments for testicular cancer: a systematic reviewR Mercieca-Bebber, SK Naher, O Rincones, AB Smith, MR StocklerPatient Related Outcome Measures, 129-171, 202192021
3-)
Patterns of care and outcomes among triple‐negative early breast cancer patients in South Western SydneyS Naher, A Tognela, E Moylan, DH Adams, BE KielyInternal Medicine Journal 48 (5), 567-572, 201872018
4-)
ALT-GIST: Randomized phase II trial of imatinib alternating with regorafenib versus imatinib alone for the first-line treatment of metastatic gastrointestinal stromal tumor (GIST).D Yip, JR Zalcberg, JY Blay, M Eriksson, D Espinoza, TJ Price, ...Journal of Clinical Oncology 37 (15_suppl), 11023-11023, 201962019
5-)
Chemotherapy in resectable or potentially resectable colon cancer with liver metastasesZ Samoon, SK Naher, KM Sjoquist, J ZalcbergExpert Opinion on Pharmacotherapy 23 (6), 663-672, 202232022
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept